Key players in Biosimilar Monoclonal Antibodies
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 2 |  Novartis AG |
novartis.com (opens in a new tab) | 1,551 reports |
| 3 |  Amgen Inc. |
amgen.com (opens in a new tab) | 693 reports |
| 4 |  Celltrion Healthcare Co |
celltrion.com (opens in a new tab) | 66 reports |
| 5 |  Allergan |
allergan.com (opens in a new tab) | 396 reports |
| 6 |  Boehringer Ingelheim GmbH |
boehringer-ingelheim.com (opens in a new tab) | 297 reports |
| 7 |  Coherus BioSciences |
coherus.com (opens in a new tab) | 33 reports |
| 8 | Biocon | — | 132 reports |
Also active in Biosimilar Monoclonal Antibodies
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Merck & Co., Inc. |
|
| Shanghai Henlius Biotech |
|
| Qilu Pharmaceutical Co., Ltd. |
|
| Alvotech Swiss AG |
|
| Innovent Biologics |
|
| mAbxience Research S.L. |
|
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
|
| Samsung Bioepis |
|
| Sandoz |
|
 Regeneron Pharmaceuticals |
|
| Libbs Farmacêutica LTDA |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Biosimilar Monoclonal Antibodies
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Merck & Co., Inc. 11 active trials on ClinicalTrials.gov (opens in a new tab)
- Shanghai Henlius Biotech 7 active trials on ClinicalTrials.gov (opens in a new tab)
- Qilu Pharmaceutical Co., Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Alvotech Swiss AG 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Innovent Biologics 2 active trials on ClinicalTrials.gov (opens in a new tab)
- mAbxience Research S.L. 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Biocon 2 active trials on ClinicalTrials.gov (opens in a new tab)
- Celltrion 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Biosimilar Monoclonal Antibodies reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Biosimilar Monoclonal Antibodies report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.